Covid-19 Prevention Strategies

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 6

TITTLE: ANALYSIS OF COVID-19 PREVENTION STRATEGIES

Introduction

The COVID-19 pandemic posed an unprecedented global challenge, requiring nations to swiftly
adapt and implement effective prevention strategies to mitigate the spread of the virus. This
paper examines the successful COVID-19 prevention strategies employed by diverse countries,
including Hungary, Greece, France, Italy, India, the United States, Algeria, Belarus, El Salvador,
and Saudi Arabia. By analyzing these strategies and their outcomes, we can extract valuable
insights into what approaches yielded positive results and contributed to the containment of the
virus.

Monitoring COVID-19 community levels to guide COVID-19 prevention efforts

The current level of COVID-19 impact in a community is enough information that a person can
use in deciding which prevention behavior can be used and specific time to be used, based on the
level of risk for illness and that of the members of their families. CDC’s COVID-19 Community
Level gives a clear picture of the effects of COVID-19 on communities and identifies the areas
that might be greatly affected by the pandemic-related outcomes, derived from the number of
beds in the hospital, the rate at which the hospital admits patients and several COVID-19
incidences recorded in the past (Lancet, (2020). The main aim of prevention measures for
COVID-19 to the community is to reduce medically significant illness and decrease strain on the
health care facilities. At the low COVID-19 community level the emphasized recommendations
include getting the vaccination, staying in well-ventilated areas, testing persons with COVID-19
symptoms, and isolating persons who are infected. At the medium level recommendation is that
the people who are at high risk be added with protection, while at the high level, people are
recommended to wear masks indoors and in public. Prevention measures will be increased or
stop basing on individual levels of risk. The COVID-19 Community Level gives a wide
framework for health officials and prevention to be used and adapted when every need arises.

Non-pharmaceutical interventions

When many prevention strategies that help individual persons and communities from SARS-
COV-2 exposure are implemented there will be reduced risk for severe illness that requires
medical attention and fatalities will reduce due to reduced risk for infection (COVID, J. (19).
There is no differentiation by the CDC’s COVID-19 prevention recommendation based on the
vaccination of the person breakthrough infection occur, though they are very small, and people
who have been infected by COVID-19 and are not vaccinated have a certain degree of protection
against severe illness from previous infection. On top of strategies recommendations for all
COVID-19 community levels education and keeping in touch will give a clear understanding of
the risks for significant illness complements recommendation for the prevention strategies based
on risk.

Testing for current infection

People are advised to undergo diagnostic testing early so that those found infected take
immediate action to reduce the risk of transmission and receive treatment to reduce the risk of
becoming severely ill and dying (Covid, W. H. O., 2020. People who are symptomatic or have
exposed themselves to someone with COVID-19 should seek testing for active infection. Public
health officers should prioritize areas that are highly populated and homeless shelters when
considering whether and where to implement screening testing of asymptomatic persons. In these
kinds of setting screening testing can be the best method for symptomatic persons by identifying
asymptomatic infected persons. Screening testing strategies should be of all people whether
vaccinated or not. Though, this method might not be cost-effective in a general community
setting if COVID-19 prevalence is low.

Isolation

Persons found to be symptomatic or infected should be isolated, and those infected should stay in
isolation for more than 5 days when out of isolation they should wear high-quality masks when
around other people for 10 days (Nussbaumer-Streit, et. al, 2020). Infected persons are advised to
end isolation only when they can stay without fever for 24 hours or more without any medication
and all the symptoms have improved. Persons who choose to use the antigen testing to know
when they can discontinue masking should take the first test on the sixth day and they are
without a fever for not less than 24 hours without any medication and all the other symptoms.
The best antigen results are achieved when it’s done within 48 hours and two consecutive results
should be negative for one to unmask.
Managing SARS-CoV-2 exposure

The recommendation by CDC is that case investigation and contact tracing be carried out in
health care settings and high-risk assemble settings, while in other cases only notification and
information are provided that expose the public to testing (Dharmaraj, J., Gunasekaran et al
2020). All persons who are suspected or confirmed to be exposed to an infected person should
wear a mask for 10 days when around others and should receive testing not less than 5 days from
the day of exposure irrespective of whether vaccinated or not. Exposed persons should reduce
public gatherings, and quarantine of exposed persons is no longer recommended irrespective of
their vaccination status.

Protecting persons most at risk for severe illness

Unfortunately, there are no pharmaceutical and medical prevention measures to be used to


decrease the risk of severe illness and death in people who are at high risk of the outcome when
infected with COVID-19 (Bialek, et al 2020). It’s only recommended that they stay up to date
with vaccination and take preventive measures which include wearing masks and avoiding large
gatherings. Public health practitioners should know the composition of their local population
when determining or adding prevention strategies that substitute disease control efforts that take
care of persons with high risk for severe illness or death.

Analysis

The successful COVID-19 prevention strategies employed by Hungary, Greece, France, Italy,
India, the United States, Algeria, Belarus, El Salvador, and Saudi Arabia underline the
importance of a multifaceted approach. Countries that combined early, decisive actions, effective
communication, robust healthcare systems, and efficient vaccine distribution achieved the most
promising outcomes. This analysis emphasizes the need for flexibility, adaptability, and a focus
on community engagement in addressing global health crises. As the world continues to navigate
the challenges posed by the pandemic, these successful strategies can serve as valuable lessons
for future preparedness and response efforts.

COVID-19 is a threat to public health, however, the availability of vaccines and infection-
induced immunity in addition to non-pharmaceutical intervention has greatly reduced the risk of
hospitalization and deaths associated with it (Park, et al 2020). In a strive to suppress its
transmission appropriate and achievable goals that are strengthened by the availability of the
modern suits of effective public health tools. Quick identification of new variants necessitates a
change in the prevention method gives continued detection and monitoring of the virus impact
into the long-term sustainable routine.
References

1. Lancet, T. (2020). Sustaining containment of COVID-19 in China. Lancet (London,


England), 395(10232), 1230.
2. COVID, J. (19). dashboard by the Center for systems science and Engineering (CSSE) at
Johns Hopkins University (JHU). 2020. Google Scholar.
3. Covid, W. H. O. (2020). Dashboard. Geneva: World Health Organization, 2020.
4. Nussbaumer-Streit, B., Mayr, V., Dobrescu, A. I., Chapman, A., Persad, E., Klerings,
I., ... & Gartlehner, G. (2020). Quarantine alone or in combination with other public
health measures to control COVID‐19: a rapid review. Cochrane Database of Systematic
Reviews, (9).
5. Murthy, S., Gomersall, C. D., & Fowler, R. A. (2020). Care for critically ill patients with
COVID-19. Jama, 323(15), 1499-1500.
6. Dharmaraj, J., Gunasekaran, C., Mohana, P., & Rajkumar, V. (2020). Treatment of
Covid-19: A review. World Journal of Biology Pharmacy and Health Sciences, 2(2),
016-029.
7. CDC Covid-19 Response Team, CDC COVID-19 Response Team, CDC COVID-19
Response Team, Bialek, S., Gierke, R., Hughes, M., ... & Skoff, T. (2020). Coronavirus
disease 2019 in children—United States, February 12–April 2, 2020. Morbidity and
Mortality Weekly Report, 69(14), 422-426.
8. Bourouiba, L. (2020). Turbulent gas clouds and respiratory pathogen emissions: potential
implications for reducing transmission of COVID-19. Jama, 323(18), 1837-1838.
9. Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020). How
will country-based mitigation measures influence the course of the COVID-19
epidemic? The Lancet, 395(10228), 931-934.
10. World Health Organization. (2020). Advice on the use of masks in the context of COVID-
19: interim guidance, 5 June 2020 (No. WHO/2019-nCoV/IPC_Masks/2020.4). World
Health Organization.
11. Painter, M., & Qiu, T. (2020). Political beliefs affect compliance with covid-19 social
distancing orders. Covid Economics, 4(April), 103-23.
12. Park, S., Choi, G. J., & Ko, H. (2020). Information technology–based tracing strategy in
response to COVID-19 in South Korea—privacy controversies. Jama, 323(21), 2129-
2130.
13. Author links open overlay panelMarcello Antonini a et al. (2021) An analysis of the
COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on
health and economic outcomes, Health Policy and Technology. Available at:
https://www.sciencedirect.com/science/article/pii/S2211883721001179?
casa_token=Xq4_Uk8wp6cAAAAA
%3Apwl1hVkm6HXhSNd1hOXQfuX9xn9ftxFr62anxO54k-
JsxitkLY7gAvrlz7KroKCLJRtXNVmCqRsP (Accessed: 13 August 2023).
14. Gohari, K. et al. (2022) ‘Clustering of countries according to the COVID-19 incidence
and mortality rates’, BMC Public Health, 22(1). doi:10.1186/s12889-022-13086-z.
15. J;, C.M.Y.X. (no date) Global Analysis of the COVID-19 policy activity levels and
evolution patterns: A cross-sectional study, Health science reports. Available at:
https://pubmed.ncbi.nlm.nih.gov/37342293/ (Accessed: 13 August 2023).
16. Li, G. et al. (2023) Therapeutic strategies for covid-19: Progress and lessons learned,
Nature News. Available at: https://www.nature.com/articles/s41573-023-00672-y
(Accessed: 13 August 2023).
17. Sun, K.S. et al. (2022) Effectiveness of different types and levels of social distancing
measures: A scoping review of global evidence from earlier stage of covid-19 pandemic,
BMJ Open. Available at: https://bmjopen.bmj.com/content/12/4/e053938.abstract
(Accessed: 13 August 2023).

You might also like